Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailLes instruments de la fiscalité environnementale
Bourgeois, Marc ULg

Conference (2008, November 13)

Detailed reference viewed: 26 (2 ULg)
Full Text
Peer Reviewed
See detailInstruments for collective design in a professional context : Digital format or new processes
Ben Rajeb, Samia ULg; Leclercq, Pierre ULg

in Proceedings of the eighth International Conference on Advances in Computer-Human Interactions, ACHI 2015 (2015)

Detailed reference viewed: 40 (7 ULg)
Full Text
See detailInstruments souples, instruments non contraignants, instruments du marché : une alternative pertinente ?
Pâques, Michel ULg

in JADOT, Benoît (Ed.) Acteurs et outils du droit de l'environnement. Développements récents, développements (peut-être) à venir (2010)

The question is whether the traditional administrative law instruments, authoritarian, are best suited for environmental protection. The rational economic agent or capitalist is not naturally inclined to ... [more ▼]

The question is whether the traditional administrative law instruments, authoritarian, are best suited for environmental protection. The rational economic agent or capitalist is not naturally inclined to protect the environment. The environmental law almost always must thwart individual liberty and the pursuit of profit or comfort. Consequently, consensual and non-binding instruments are not the most naturally suited to protecting the environment. The main legal instruments of environmental law are reviewed: prohibition, authorization, non-legal action, gentlemen's agreements, contracts, tax incentives, market pollution… [less ▲]

Detailed reference viewed: 84 (4 ULg)
Full Text
Peer Reviewed
See detailL'insuffisance cardiaque du sujet age.
D'ORIO, Virginie ULg; LANCELLOTTI, Patrizio ULg; Pierard, Luc ULg

in Revue medicale de Liege (2014), 69(5-6), 309-14

Heart failure in the elderly represents a major public health problem.In this population, the general objective of therapy, defined by current guidelines, does not differ from that proposed for younger ... [more ▼]

Heart failure in the elderly represents a major public health problem.In this population, the general objective of therapy, defined by current guidelines, does not differ from that proposed for younger patients: the aims are to decrease symptoms, to improve quality of life, to decrease hospitalizations, and to increase survival. However, in this category of patients, respect for autonomy and quality of life remains a priority, and requires a personalized approach because of the geriatric characteristics of many patients. [less ▲]

Detailed reference viewed: 64 (7 ULg)
Full Text
Peer Reviewed
See detailInsuffisance cardiaque et diabete
ANCION, A.; Lancellotti, Patrizio ULg; Pierard, Luc ULg

in Revue Médicale de Liège (2005), 60(5-6, May-Jun), 536-40

Diabetic patients frequently develop heart failure and have a guarded prognosis because of the combination of diabetic cardiomyopathy, hypertension and ischaemic heart disease. The lack of patient ... [more ▼]

Diabetic patients frequently develop heart failure and have a guarded prognosis because of the combination of diabetic cardiomyopathy, hypertension and ischaemic heart disease. The lack of patient awareness of the association between diabetes and cardiovascular disease contributes to the risk of heart failure in the diabetic population. Therefore, physicians should consider the risk of comorbidities and use appropriate screening tests to achieve early identification and initiate preventive strategies. There is evidence suggesting that adequate glycaemic control may improve cardiac metabolism and myocardial function in diabetics with heart failure. Improvement in cardiac function engendered by neurohumoral inhibition is associated with a decrease in mortality that is at least as great in the diabetic patients with heart failure as it is in the non diabetic patients. However, several therapeutic interventions have not yet been specifically validated in diabetic subjects. Thus, physicians should be encouraged to use therapies tested in the diabetic population, such as B-blockers and ACE inhibitors. Diabetic patients would benefit from more aggressive preventive programs aimed at reducing the incidence of cardiovascular morbidity and mortality. [less ▲]

Detailed reference viewed: 12 (4 ULg)
Full Text
Peer Reviewed
See detailInsuffisance cardiaque et diabete de type 2: une relation a double sens.
De Flines, Jenny ULg; Scheen, André ULg

in Revue Médicale de Liège (2007), 62(2), 112-7

The present article analyses the intimate relationship between diabetes mellitus and congestive heart failure. This relationship is indeed "bidirectional". On the one hand, it is well known that diabetes ... [more ▼]

The present article analyses the intimate relationship between diabetes mellitus and congestive heart failure. This relationship is indeed "bidirectional". On the one hand, it is well known that diabetes mellitus, especially type 2 diabetes, predisposes to congestive heart failure due to intricated mechanisms. In most cases, there is a combination of various well-known risk factors, such as obesity, arterial hypertension and coronary heart disease, with a specific diabetic cardiomyopathy, whose pathophysiology is complex. On the other hand, several studies showed that congestive heart failure increases the risk of new type 2 diabetes, probably due to decreased muscular perfusion and excessive neurohumoral response. Remarkably, such a risk could be reduced by a drug capable of inhibiting the renin-angiotensin system, as previously reported in patients with arterial hypertension. The recent launch and the increasing use of thiazolidinediones (glitazones) raise the interest for congestive heart failure in diabetic patients. Indeed, because of their positive effect on insulin resistance and various pleiotropic effects, glitazones may exert some cardiovascular protection; however, both rosiglitazone and pioglitazone are associated with fluid retention, which could reveal or aggravate episodes of congestive heart failure. [less ▲]

Detailed reference viewed: 119 (1 ULg)
Full Text
See detailInsuffisance hépatique aigue: traitement conservateur et alternatives thérapeutiques
DETRY, Olivier ULg

Conference (2015, November 17)

Detailed reference viewed: 34 (2 ULg)
See detailInsuffisance hépatique et rénale secondaire à une intoxication au trichloréthylène
Misson, Jean-Paul ULg; Mossay, Christian; Francotte, Nadine et al

in Acta Paediatrica Belgica (1983)

Detailed reference viewed: 17 (3 ULg)
See detailInsuffisance hypophysaire et amaurose subaiguës causées par une pseudotumeur inflammatoire extensive du sinus sphénoïde
Hansen, Isabelle ULg; Petrossians, Patrick ULg; Flandroy, Pierre et al

in XVI Congrès de la Société Française d'Endocrinologie - Abstract book (1998)

Detailed reference viewed: 47 (0 ULg)
Full Text
Peer Reviewed
See detailL’insuffisance mitrale chez le cheval : revue de la littérature et comparaison avec la pathologie chez l’homme et chez le chien
Al Haidar, Ali; Leroux, Aurélia ULg; Amory, Hélène ULg

in Annales de Médecine Vétérinaire (2013), 157(1), 52-68

Abstract Mitral regurgitation (MR) is a one of the most common cardiac disease in the equine species. Furthermore, it is the valvular disease that presents the higher risk to be associated with reduced ... [more ▼]

Abstract Mitral regurgitation (MR) is a one of the most common cardiac disease in the equine species. Furthermore, it is the valvular disease that presents the higher risk to be associated with reduced athletic performance, to evolve into congestive heart failure and to become life threatening. The clinical diagnosis of MR depends mainly on the expertise of the veterinarian in cardiology and is above all based on cardiac auscultation. In all of the cases, the definitive diagnosis and the evaluation of the disease severity require performing a Doppler echocardiographic examination. Signs of left ventricular and/or left atrial overload, large regurgitation jet, pulmonary arterial hypertension or significant arrhythmias are negative prognosis factors. Clinical signs of congestive heart failure make the prognosis worse. Other echocardiographic parameters are used in human and dogs in order to determine the severity of the MR, but have been not validated in horses. Treatment of mitral regurgitation in the equine species is symptomatic and directed against the development of a congestive heart failure. A lot of drugs that are used in human or dogs are of limited value in horses for financial reasons and/or lack of pharmacokinetics and pharmacologic data in equine species. [less ▲]

Detailed reference viewed: 91 (34 ULg)
Full Text
Peer Reviewed
See detailL’insuffisance mitrale chez le cheval : revue de littérature.
Maurin, Emmanuel; Amory, Hélène ULg; Sandersen, Charlotte ULg

in Pratique Vétérinaire Equine (2003), 35

Detailed reference viewed: 38 (2 ULg)
See detailL'insuffisance mitrale dynamique : rôle de l'échocardiographie d'effort
LANCELLOTTI, Patrizio ULg

Post doctoral thesis (2005)

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailL'insuffisance mitrale ischemique.
Lancellotti, Patrizio ULg; Moonen, Marie ULg; Zacharakis, Dimitri et al

in Archives des Maladies du Coeur et des Vaisseaux (2007), 100(12), 1056-62

Mitral regurgitation (MR) is a serious complication of coronary heart disease. The functional form is the most frequent, often presenting with a dynamic character. The presence, and in particular the ... [more ▼]

Mitral regurgitation (MR) is a serious complication of coronary heart disease. The functional form is the most frequent, often presenting with a dynamic character. The presence, and in particular the severity of MR and its dynamic character have a major impact on the medium and long term prognosis. The mechanisms responsible for MR are complex and occur in a state of disequilibrium between traction forces and closing forces, for which the significance is partly affected by the presence of asynchrony in left ventricular contraction. The therapeutic management of these patients is difficult. In cases of proven asynchrony, implantation of a biventricular pacemaker is justified. A mitral surgical procedure may be envisaged in cases of severe MR where bypass surgery is planned. In cases of moderate MR at rest, an evaluation of its dynamic character on effort can assist with the decision to undertake combined surgery. Mitral regurgitation (MR) is a common and serious complication of ischemic heart disease. Three general forms are distinguished: MR related to acute rupture of the mitral pillar, ischemic MR and functional MR. [less ▲]

Detailed reference viewed: 76 (7 ULg)
Full Text
Peer Reviewed
See detailL'insuffisance mitrale par degenerescence myxoide: aspect biochimique et considerations physiopathologiques.
Radermecker, Marc ULg; Boulanger, Kevin ULg; Hulin, Alexia ULg et al

in Revue Médicale de Liège (2008), 63(4), 187-92

Mitral valve is a complex structure which is submitted to repeated mechanical constraints. In clinical practice, an increasing incidence of mitral insufficiency resulting from myxomatous degeneration is ... [more ▼]

Mitral valve is a complex structure which is submitted to repeated mechanical constraints. In clinical practice, an increasing incidence of mitral insufficiency resulting from myxomatous degeneration is observed. Since myxomatous degeneration is also observed in defined genetic diseases of connective tissues, we propose the hypothesis that idiopathic mitral insufficiency might result from a minor alteration of the interstitial valvular cells and/or their interactions with their support. After a brief review of the role of the extracellular matrix in the heart, some histopathological and biochemical aspects of myxomatous degeneration are presented. Our data and those of the literature will be summarized and a physiopathological hypothesis proposed for myxomatous mitral valve degeneration. [less ▲]

Detailed reference viewed: 292 (7 ULg)
See detailInsuffisance mitrate primaire: indications chirurgicales et dernieres avancees.
Voilliot, D.; Henri, C.; Pierard, Luc ULg

in Revue medicale suisse (2013), 9(395), 1518-21

Mitral regurgitation (MR) is, in Europe, the second most common valvular disease. Primary MR represents 61% of cases. The surgical indications for symptomatic patients with severe primary MR, are subject ... [more ▼]

Mitral regurgitation (MR) is, in Europe, the second most common valvular disease. Primary MR represents 61% of cases. The surgical indications for symptomatic patients with severe primary MR, are subject to a broad consensus with strong levels of recommendations. In asymptomatic patients, levels of recommendations are weaker despite the numerous publications. Exercise echocardiography has emerged as a useful tool for the management of the patients and appeared in the latest European recommendations. It continues to be the subject of numerous studies demonstrating its usefulness for risk stratification in asymptomatic patients. The next advances in this field will probably argue for an earlier surgery in these kinds of patients. [less ▲]

Detailed reference viewed: 19 (2 ULg)
Full Text
Peer Reviewed
See detailInsuffisance ovarienne prématurée : de la génétique à la clinique
Rege, G; Foidart, Jean-Michel ULg; NISOLLE, Michelle ULg et al

in Revue Médicale de Liège (2012), 67(7-8), 413-419

L’Insuffisance Ovarienne Prématurée (IOP) est une pathologie dont la présentation clinique est complexe. Elle survient chez 1% des femmes avant 40 ans, 0,1% avant 30 ans. Les causes sont multiples : les ... [more ▼]

L’Insuffisance Ovarienne Prématurée (IOP) est une pathologie dont la présentation clinique est complexe. Elle survient chez 1% des femmes avant 40 ans, 0,1% avant 30 ans. Les causes sont multiples : les anomalies génétiques, les maladies auto-immunes, les atteintes ovariennes iatrogènes secondaires à la chirurgie, radiothérapie, chimiothérapie, aux facteurs environnementaux tels que les virus, les toxines, le tabac, et aux facteurs métaboliques. Cependant, dans la majorité des cas, l’étiologie de l’IOP est idiopathique. [less ▲]

Detailed reference viewed: 58 (10 ULg)
See detailL'insuffisance rénale : fatalité liée à l'âge?
Krzesinski, Jean-Marie ULg

Conference (2011, November 08)

Detailed reference viewed: 12 (0 ULg)
Full Text
See detailInsuffisance rénale aiguë : définition, monitorage et traitement NON dialytique
Krzesinski, Jean-Marie ULg

Scientific conference (2014, October 25)

Detailed reference viewed: 24 (2 ULg)